{
    "2021-12-29": [
        [
            {
                "time": "",
                "original_text": "西,南,证,券,医,药,2,0,2,2,年,度,策,略,：,未,来,医,药,估,值,有,望,均,衡,，,“,穿,越,医,保,”,和,“,疫,情,脱,敏,”,是,两,条,核,心,主,线",
                "features": {
                    "keywords": [
                        "医药",
                        "估值",
                        "均衡",
                        "穿越医保",
                        "疫情脱敏",
                        "核心主线"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}